Parenteral Routes (IV, IM, SC)

Parenteral administration delivers a drug by injection, bypassing the gastrointestinal tract. The main parenteral routes are intravenous (directly into a vein), intramuscular (into a muscle), and subcutaneous (into the tissue beneath the skin). Because they avoid the absorption and first-pass barriers of oral dosing, parenteral routes give predictable systemic exposure and, in the intravenous case, immediate and complete availability of the drug.

Definition

Parenteral administration is delivery of a drug by injection into the body, most commonly intravenously, intramuscularly, or subcutaneously, bypassing gastrointestinal absorption and first-pass metabolism.

Scope

This topic covers the principal injection routes, how each governs the rate and completeness of drug entry into the circulation, and the formulation requirements (sterility, particle size, depot behavior) specific to injectable products. It is a pharmaceutical reference and does not provide dosing, injection technique, or clinical administration guidance.

Core questions

• How do intravenous, intramuscular, and subcutaneous routes differ in the rate and completeness of systemic entry?
• Why does the subcutaneous route expose large molecules to lymphatic transport?
• What formulation constraints (sterility, solubility, particle size) apply to injectable products?
• How can injectable formulations be designed for sustained or depot release?

Key concepts

• Intravenous administration
• Intramuscular administration
• Subcutaneous administration
• Complete bioavailability (IV)
• Lymphatic absorption
• Depot formulation
• Sterility and parenteral quality

Mechanisms

Intravenous injection places the drug directly into the bloodstream, giving immediate and by definition complete systemic availability without an absorption step. Intramuscular and subcutaneous injections deposit the drug into tissue, from which it must be absorbed; the rate depends on local blood flow, the injection volume, and the drug's properties. For the subcutaneous route, larger molecules such as proteins are absorbed partly through the lymphatic system rather than directly into blood capillaries, which affects their rate and pattern of entry (McLennan et al., 2005; Di, 2015). Because injectables enter sterile tissues, they must meet stringent requirements for sterility and freedom from particulates, and poorly soluble drugs may be formulated as nanosuspensions or depot systems to control release (Rabinow, 2004).

Clinical relevance

Parenteral routes are used when reliable, rapid, or complete systemic exposure is needed or when a drug cannot survive the oral route, and understanding their behavior supports appraisal of why certain medicines are injectable. This entry describes route and formulation principles for reference and is not a basis for administration or dosing decisions in any individual.

Evidence & guidelines

Reviews of subcutaneous delivery describe the lymphatic absorption of macromolecules (McLennan et al., 2005; Di, 2015), and reviews of injectable nanosuspensions cover formulation of poorly soluble drugs for parenteral use (Rabinow, 2004). Standard pharmaceutics texts codify parenteral product requirements (Aulton & Taylor, 2018).

History

Injectable medicines became practical with the development of the hypodermic syringe in the nineteenth century and matured through twentieth-century advances in sterile manufacturing. More recent work has focused on the distinct absorption of subcutaneously delivered biologics via the lymphatics and on engineered injectable formulations such as nanosuspensions and long-acting depots (McLennan et al., 2005; Rabinow, 2004).

Key figures

• Christopher Porter
• Susan Charman
• Barrett Rabinow

Seminal works

• mclennan-2005
• rabinow-2004

Frequently asked questions

Why is intravenous administration said to have complete bioavailability?

Because the drug is placed directly into the bloodstream, there is no absorption step to lose any of it, so by definition the entire dose reaches the systemic circulation.

How does subcutaneous delivery of large molecules differ from small drugs?

Large molecules such as proteins given subcutaneously are absorbed substantially through the lymphatic system rather than directly into blood capillaries, which changes how quickly and completely they enter the circulation.